1.
Aguilar C, Rodríguez-Delfín L. Effects of spironolactone administration on the podocytes loss and progression of experimental diabetic nephropathy. Rev Peru Med Exp Salud Publica. 2014;29(4). doi:10.17843/rpmesp.2012.294.393